Insiders Keymed Biosciences Inc.

Equities

Delayed Hong Kong S.E. Other stock markets 01:06:12 14/05/2024 pm IST			5-day change	1st Jan Change
39.8 ^HKD	-4.33%		+12.22%	-18.64%

30/04	Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA	MT
29/04	Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points	MT

Keymed Biosciences Inc. Announces Board and Committee Changes	17/23/17	CI
Keymed Biosciences Inc. Announces Executive Changes	29/22/29	CI
Keymed Biosciences Inc. Announces Resignation of Dong Lyu as Non-Executive Director	29/22/29	CI

No results for this search